spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Bioeq 

 HSMN NewsFeed - 23 Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Jan 2025
UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX(R) (bimekizumab-bkzx)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 8 Apr 2024
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS(R) (edaravone)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Aug 2023
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Aug 2022
Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Aug 2021
SKYRIZI(R) (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 30 Jun 2021
Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 5 Nov 2020
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Oct 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI(R) Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Oct 2018
Rockwell Medical Provides Update on IV Triferic
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jul 2018
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA(R) (Tesamorelin for Injection) for FDA Approval
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 28 Jun 2018
Biohaven Expands Rimegepant Development Program to Include New Prevention of Migraine Phase 3 Trial and Highlights Key Late-Breaking Presentations at American Headache Society (AHS) Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Apr 2018
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Apr 2018
Duchesnay USA Announces Launch of Bonjesta(R) (doxylamine succinate - pyridoxine hydrochloride) in the United States
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 5 Feb 2018
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 18 Jan 2018
Aquestive Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Clobazam Oral Soluble Film to Treat Lennox-Gastaut Syndrome
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 2 Oct 2017
Biohaven Reports Negative Topline Data from Spinocerebellar Ataxia (SCA) Phase 2/3 Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Apr 2017
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sarcomas
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Apr 2017
AMAG Submits Supplemental New Drug Application to FDA for Makena(R) (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 3 Feb 2017
Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista(TM) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Nov 2016
Intellipharmaceutics Submits New Drug Application for Rexista(R) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2016
Marina Biotech Announces Merger with IthenaPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2016
Eagle Pharmaceuticals Announces Changes to Its Board of Directors; Director, Michael Graves Appointed Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2016
Catalyst Pharmaceuticals Announces Reduction in Workforce as Part of Operating Expense Management Plan
Biopharmaceuticals
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 24 Mar 2016
Ajanta Pharma Announces the Launch of Levetiracetam Tablets
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Feb 2016
Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2016
Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Nov 2015
RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT(TM) (RHB-103) for Migraines
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 23 Oct 2015
Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA(TM) (melphalan) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jul 2015
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 24 Dec 2014
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2014
Spectrum Pharmaceuticals’ Pivotal Trial of Captisol-Enabled(TM) (Propylene Glycol-Free) Melphalan Meets Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Sep 2013
Perrigo Company Appoints FDA Veteran As New Head Of Regulatory Review
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2013
Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jul 2013
AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Aug 2012
Sanofi Announces FDA Approval for Auvi-Q(TM), First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 May 2012
Acella Pharmaceuticals, LLC, Announces Approval of Generic Gabapentin Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 25 Jul 2011
ADVENTRX Announces Appointment of Senior Vice President, Commercial
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2011
Shire Files Lawsuit Against Watson Pharmaceuticals, Inc. for Infringement of ADDERALL XR(R) Patents and for Breach of Contract
Biopharmaceuticals Litigation
 HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Sep 2010
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 14 Jul 2010
Mylan Receives Approval for Nabumetone Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jul 2010
MonoSol Rx Announces FDA Approval of Zuplenz(R) Oral Soluble Film for Treatment of Nausea and Vomiting
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 3 Jun 2010
Taro Receives FDA Approval for Granisetron Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2010
Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2010
ADVENTRX Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2010
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Oct 2009
Zogenix and Astellas Announce Data Published Showing the Benefits of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2009
Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2009
Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jun 2009
Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 22 Apr 2009
Metabolex Announces Election of Kurt von Emster to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2009
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
Biopharmaceuticals
 HSMN NewsFeed - 2 Apr 2009
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 5 Mar 2009
European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 17 Feb 2009
Break-through Drug for Heart Failure in Dogs Now Available in the United States
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Feb 2009
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
Diagnostics Oncology
 HSMN NewsFeed - 15 Dec 2008
ADVENTRX Exploring Strategic Options
Biopharmaceuticals
 HSMN NewsFeed - 8 Dec 2008
CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Oct 2008
MDS Pharma Services Takes Novel Steps to Recruit Patients for Alzheimer’s Disease Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2008
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Biopharmaceuticals Generics Neurology FDA Litigation
 HSMN NewsFeed - 26 Jun 2008
MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 2 Jun 2008
MethylGene Reports Clinical Data for MGCD0103 at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2008
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 May 2008
NovaDel Announces European License Agreement for Ondansetron Oral Spray
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Apr 2008
Taro Receives Tentative FDA Approval for Lamotrigine Tablets ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Apr 2008
MDS Pharma Services Names Teresa Winslow and James Miskel to Senior Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
MPM Capital and NEA Lead $65 million Series A Preferred Round to Finance Spinout of TriVascular from Boston Scientific
Devices Interventional Venture Capital
 HSMN NewsFeed - 25 Mar 2008
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Mar 2008
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro(TM) to Desitin Pharmaceuticals, GmbH
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 5 Mar 2008
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 14 Feb 2008
MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Feb 2008
MethylGene and Pharmion Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 30 Jan 2008
Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 25 Jan 2008
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 23 Jan 2008
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 Jan 2008
NitroMed Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2008
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Biopharmaceuticals Endocrinology Generics FDA
 HSMN NewsFeed - 14 Jan 2008
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Children's Zyrtec(R) Chewable Tablets for Allergy Relief and Children's Zyrtec(R) Chewable Tablets for Hives Relief
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Jan 2008
ViroPharma Provides Update on Vancocin(R)
Biopharmaceuticals
 HSMN NewsFeed - 28 Dec 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Dec 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 30 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Nov 2007
ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Nov 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Nov 2007
Acusphere to Develop Potential Abraxane(R) Bioequivalent
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Oct 2007
Allozyne, Inc., Closes $30 Million Series B Financing and Appoints Meenu Chhabra as President and Chief Executive Officer
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 11 Oct 2007
Akorn, Inc. Signs an Exclusive Licensing, Development and Supply Agreement with Sofgen Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Oct 2007
ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Oct 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 5 Sep 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 22 Aug 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Aug 2007
Synovics Pharmaceuticals Announces the Settlement of all Legal Proceedings with Nostrum Pharmaceuticals, Inc., Dr. Nirmal Mulye and Anil Anand
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Aug 2007
NovaDel Announces Sublicense Agreement for Zensana(TM)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Jul 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Jul 2007
Synovics Pharmaceuticals Appoints Steven Getraer as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 May 2007
Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Apr 2007
Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Nimotop(R)
Biopharmaceuticals Cardiology Generics
 HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Apr 2007
Synovics Pharmaceuticals Appoints David Coffin-Beach President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2007
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Apr 2007
Metabolex Raises $32 Million to Accelerate Clinical Development Programs for Its Pipeline of Drug Candidates in Metabolic Disease
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 12 Apr 2007
Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Apr 2007
Syndax Pharmaceuticals Inc. Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2007
FDA Approves JANUMET(TM) for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 22 Mar 2007
GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Mar 2007
Synovics Pharmaceuticals Files ANDA for Generic Hydroxyzine
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Feb 2007
NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by Hana BioSciences
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2007
Hana Biosciences Reports Likely Delay in Launch of Zensana(TM)
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2007
Ranbaxy Gains Final Approval for Sertraline Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Feb 2007
Ranbaxy Receives Final FDA Approval to Manufacture and Market Valacyclovir HCl Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jan 2007
Ranbaxy Gains FDA Approval to Market Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Jan 2007
Mylan's Levothyroxine Sodium Tablets USP Approved as Generic Equivalent to Levothroid(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Dec 2006
Bentley Pharmaceuticals' Generic Simvastatin Approved for U.S. Market
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 21 Dec 2006
Ranbaxy Granted Final FDA Approval to Market Simvastatin 5, 10, 20 and 40 mg Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Dec 2006
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
Biopharmaceuticals Drug Delivery Generics FDA
 HSMN NewsFeed - 15 Dec 2006
Caraco Pharmaceutical Laboratories Ltd. to Market Extended Phenytoin Sodium Capsules, USP 100mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Nov 2006
OREXIGEN(TM) Therapeutics Completes $30 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Nov 2006
Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
Biopharmaceuticals
 HSMN NewsFeed - 15 Nov 2006
Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 1 Nov 2006
Synovics Pharmaceuticals Initiates U.S. Development of Its Fourth Generic Oral Controlled-Release Drug
Biopharmaceuticals Generics
 HSMN NewsFeed - 17 Oct 2006
Endo Pharmaceuticals Comments on Lidoderm(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Oct 2006
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 26 Sep 2006
Axcan and AGI Therapeutics Sign Exclusive License and Co-Development Agreement for the Next-Generation Therapy for GERD and the Control of Nocturnal Acid Breakthrough
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 21 Sep 2006
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Sep 2006
Ranbaxy Receives FDA Approval to Market Loperamide Hydrochloride and Simethicone Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Jul 2006
ISTA Pharmaceuticals Files New Drug Application with U.S. Food and Drug Administration for T-Pred(TM), a Tobramycin and Prednisolone Acetate Combination Product
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 Jul 2006
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Cipher appoints Vice President of Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2006
Ranbaxy Receives Approval To Market Doxycycline Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 May 2006
Synovics Pharmaceuticals, Inc. Announces a Key New Member Joins Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2006
Synovics Pharmaceuticals, Inc. Announces Acquisition of its First Application for Approval of a Generic Drug with the FDA
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Biopharmaceuticals Dermatology FDA
Return to NewsFeed  

 Additional items found! 153

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 153 additional stories matching:
Bioeq
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!